In vivo administration of the recombinant IL-7/hepatocyte growth factor β hybrid cytokine efficiently restores thymopoiesis and naive T cell generation in lethally irradiated mice after syngeneic bone marrow transplantation

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 1915-1922

  Jin, Jingjun ^a   Goldschneider, Irving ^a   Lai, Laijun ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; IMMUNOLOGIC AGENT; INTERLEUKIN 7 RECEPTOR ALPHA; L SELECTIN; RECOMBINANT INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 7 HEPATOCYTE GROWTH FACTOR BETA; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG HALF LIFE; IMMUNE DEFICIENCY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE DEFICIENCY; THYMOCYTE; THYMUS;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, CIRCULAR; G0 PHASE; HEPATOCYTE GROWTH FACTOR; INTERLEUKIN-7; MICE; PLASMIDS; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; STROMAL CELLS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSPLANTATION, ISOGENEIC;

EID: 79951849281     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001238     Document Type: Article

References (55)

1. Williams, K. M., F. T. Hakim, and R. E. Gress. 2007. T cell immune reconstitution following lymphodepletion. Semin. Immunol. 19: 318-330.
2. van den Brink, M. R., O. Alpdogan, and R. L. Boyd. 2004. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat. Rev. Immunol. 4: 856-867.
3. Zediak, V. P., and A. Bhandoola. 2005. Aging and T cell development: interplay between progenitors and their environment. Semin. Immunol. 17: 337-346.
4. Lynch, H. E., G. L. Goldberg, A. Chidgey, M. R. Van den Brink, R. Boyd, and G. D. Sempowski. 2009. Thymic involution and immune reconstitution. Trends Immunol. 30: 366-373.
5. McKenna, S. D., F. Chen, L. Lai, and I. Goldschneider. 1998. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice. J. Immunol. 160: 2272-2279.
6. Lai, L., F. Chen, S. D. McKenna, and I. Goldschneider. 1998. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). II. PPBSF is a covalently linked heterodimer of IL-7 and a Mr 30,000 cofactor. J. Immunol. 160: 2280-2286.
7. Lai, L., and I. Goldschneider. 2001. Cutting edge: Identification of a hybrid cytokine consisting of IL-7 and the b-chain of the hepatocyte growth factor/scatter factor. J. Immunol. 167: 3550-3554. (Pubitemid 32910794)
8. Lai, L., R. A. Zeff, and I. Goldschneider. 2006. A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and prepro-B cells. Blood 107: 1776-1784. (Pubitemid 43289353)
9. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
10. Abdul-Hai, A., R. Or, S. Slavin, G. Friedman, L. Weiss, D. Matsa, and A. Ben-Yehuda. 1996. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp. Hematol. 24: 1416-1422.
11. Bolotin, E., M. Smogorzewska, S. Smith, M. Widmer, and K. Weinberg. 1996. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88: 1887-1894. (Pubitemid 26307089)
12. Mackall, C. L., T. J. Fry, C. Bare, P. Morgan, A. Galbraith, and R. E. Gress. 2001. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97: 1491-1497.
13. Alpdogan, O., C. Schmaltz, S. J. Muriglan, B. J. Kappel, M. A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. van den Brink. 2001. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98: 2256-2265.
14. Broers, A. E., S. J. Posthumus-van Sluijs, H. Spits, B. van der Holt, B. Löwenberg, E. Braakman, and J. J. Cornelissen. 2003. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 102: 1534-1540.
15. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299. (Pubitemid 36302072)
16. Mathur, A., D. A. Vallera, P. A. Taylor, M. B. Widmer, C. Yang, A. Prabhu, and B. R. Blazar. 1995. Effect of IL-7 or IL-4 on reconstitution of donor lymphoid cells in congenic murine bone marrow transplantation. Bone Marrow Transplant. 16: 119-124.
17. Storek, J., T. Gillespy, III, H. Lu, A. Joseph, M. A. Dawson, M. Gough, J. Morris, R. C. Hackman, P. A. Horn, G. E. Sale, et al. 2003. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 101: 4209-4218. (Pubitemid 36857906)
18. Chu, Y. W., S. A. Memon, S. O. Sharrow, F. T. Hakim, M. Eckhaus, P. J. Lucas, and R. E. Gress. 2004. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 104: 1110-1119.
19. Sportès, C., F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al. 2008. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205: 1701-1714.
20. Phillips, J. A., T. I. Brondstetter, C. A. English, H. E. Lee, E. L. Virts, and M. L. Thoman. 2004. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J. Immunol. 173: 4867-4874.
21. Imado, T., T. Iwasaki, Y. Kataoka, T. Kuroiwa, H. Hara, J. Fujimoto, and H. Sano. 2004. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 104: 1542-1549. (Pubitemid 39166536)
22. Lai, L., and J. Jin. 2009. Generation of thymic epithelial cell progenitors by mouse embryonic stem cells. Stem Cells 27: 3012-3020.
23. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, H. Yoshida, and S. Nishikawa. 1993. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 90: 9125-9129.
24. Lenz, D. C., S. K. Kurz, E. Lemmens, S. P. Schoenberger, J. Sprent, M. B. Oldstone, and D. Homann. 2004. IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc. Natl. Acad. Sci. USA 101: 9357-9362.
25. Gray, D. H., A. P. Chidgey, and R. L. Boyd. 2002. Analysis of thymic stromal cell populations using flow cytometry. J. Immunol. Methods 260: 15-28.
26. Allman, D., A. Sambandam, S. Kim, J. P. Miller, A. Pagan, D. Well, A. Meraz, and A. Bhandoola. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4: 168-174.
27. Chu, Y. W., S. Schmitz, B. Choudhury, W. Telford, V. Kapoor, S. Garfield, D. Howe, and R. E. Gress. 2008. Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion. Blood 112: 2836-2846.
28. Min, H., E. Montecino-Rodriguez, and K. Dorshkind. 2004. Reduction in the developmental potential of intrathymic T cell progenitors with age. J. Immunol. 173: 245-250. (Pubitemid 38797348)
29. Porritt, H. E., L. L. Rumfelt, S. Tabrizifard, T. M. Schmitt, J. C. Zúñiga-Pflücker, and H. T. Petrie. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20: 735-745.
30. Stoklasek, T. A., K. S. Schluns, and L. Lefrançois. 2006. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177: 6072-6080. (Pubitemid 44628822)
31. Paulsson, G., X. Zhou, E. Törnquist, and G. K. Hansson. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 10-17.
32. Capitini, C. M., A. A. Chisti, and C. L. Mackall. 2009. Modulating T-cell homeostasis with IL-7: preclinical and clinical studies. J. Intern. Med. 266: 141-153.
33. Van De Wiele, C. J., J. H. Marino, B. W. Murray, S. S. Vo, M. E. Whetsell, and T. K. Teague. 2004. Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. J. Immunol. 172: 4235-4244.
34. Anderson, G.,W. E. Jenkinson, T. Jones, S.M. Parnell, F. A. Kinsella, A. J. White, J. E. Pongrac'z, S. W. Rossi, and E. J. Jenkinson. 2006. Establishment and functioning of intrathymic microenvironments. Immunol. Rev. 209: 10-27.
35. Chidgey, A., J. Dudakov, N. Seach, and R. Boyd. 2007. Impact of niche aging on thymic regeneration and immune reconstitution. Semin. Immunol. 19: 331-340.
36. Brugnera, E., A. Bhandoola, R. Cibotti, Q. Yu, T. I. Guinter, Y. Yamashita, S. O. Sharrow, and A. Singer. 2000. Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity 13: 59-71.
37. Kelly, R. M., E. M. Goren, P. A. Taylor, S. N. Mueller, H. E. Stefanski, M. J. Osborn, H. S. Scott, E. A. Komarova, A. V. Gudkov, G. A. Holländer, and B. R. Blazar. 2010. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 115: 1088-1097.
38. Min, D., P. A. Taylor, A. Panoskaltsis-Mortari, B. Chung, D. M. Danilenko, C. Farrell, D. L. Lacey, B. R. Blazar, and K. I. Weinberg. 2002. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99: 4592-4600.
39. Alpdogan, O., S. J. Muriglan, J. M. Eng, L. M. Willis, A. S. Greenberg, B. J. Kappel, and M. R. van den Brink. 2003. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112: 1095-1107.
40. Bui, T., C. Faltynek, and R. J. Ho. 1994. Differential disposition of soluble and liposome-formulated human recombinant interleukin-7: effects on blood lymphocyte population in guinea pigs. Pharm. Res. 11: 633-641.
41. Morrissey, P. J., P. Conlon, K. Charrier, S. Braddy, A. Alpert, D. Williams, A. E. Namen, and D. Mochizuki. 1991. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J. Immunol. 147: 561-568.
42. Morrissey, P. J., P. Conlon, S. Braddy, D. E. Williams, A. E. Namen, and D. Y. Mochizuki. 1991. Administration of IL-7 to mice with cyclophosphamide- induced lymphopenia accelerates lymphocyte repopulation. J. Immunol. 146: 1547-1552.
43. El Kassar, N., P. J. Lucas, D. B. Klug, M. Zamisch, M. Merchant, C. V. Bare, B. Choudhury, S. O. Sharrow, E. Richie, C. L. Mackall, and R. E. Gress. 2004. A dose effect of IL-7 on thymocyte development. Blood 104: 1419-1427.
44. Fry, T. J., and C. L. Mackall. 2002. Interleukin-7: from bench to clinic. Blood 99: 3892-3904.
45. Cosenza, L., G. Gorgun, A. Urbano, and F. Foss. 2002. Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cell. Signal. 14: 317-325.
46. Kitazawa, H., K. Muegge, R. Badolato, J. M. Wang, W. E. Fogler, D. K. Ferris, C. K. Lee, S. Candéias, M. R. Smith, J. J.Oppenheim, and S. K. Durum. 1997. IL-7 activates alpha4beta1 integrin in murine thymocytes. J. Immunol. 159: 2259-2264.
47. Schmitt, N., L. Chêne, D. Boutolleau, M. T. Nugeyre, E. Guillemard, P. Versmisse, C. Jacquemot, F. Barré-Sinoussi, and N. Israël. 2003. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. J. Virol. 77: 5784-5793. (Pubitemid 36538971)
48. Kollet, O., S. Shivtiel, Y. Q. Chen, J. Suriawinata, S. N. Thung, M. D. Dabeva, J. Kahn, A. Spiegel, A. Dar, S. Samira, et al. 2003. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 112: 160-169.
49. Matsuda-Hashii, Y., K. Takai, H. Ohta, H. Fujisaki, S. Tokimasa, Y. Osugi, K. Ozono, K. Matsumoto, T. Nakamura, and J. Hara. 2004. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp. Hematol. 32: 955-961.
50. Weimar, I. S., D. de Jong, E. J. Muller, T. Nakamura, J. M. van Gorp, G. C. de Gast, and W. R. Gerritsen. 1997. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood 89: 990-1000.
51. Li, W. Q., Q. Jiang, A. R. Khaled, J. R. Keller, and S. K. Durum. 2004. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J. Biol. Chem. 279: 29160-29166.
52. Rubin, J. S., D. P. Bottaro, and S. A. Aaronson. 1993. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta 1155: 357-371.
53. Carrio, R., N. H. Altman, and D. M. Lopez. 2009. Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice. Cancer Immunol. Immunother. 58: 2059-2072.
54. Sportès, C., R. R. Babb, M. C. Krumlauf, F. T. Hakim, S. M. Steinberg, C. K. Chow, M. R. Brown, T. A. Fleisher, P. Noel, I. Maric, et al. 2010. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin. Cancer Res. 16: 727-735.
55. Boyman, O., C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh. 2008. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J. Immunol. 180: 7265-7275.